21 November 2023>: Original Paper
Predictors of Long-Term Outcomes After Liver Transplantation for Unresectable Metastatic Neuroendocrine Tumors
Mikołaj Kuncewicz 1BCDEF , Igor Piotr Jaszczyszyn 1BCDE , Kacper Karaban 1BCDE , Paweł Rykowski 1DEF* , Maciej Krasnodębski 1ADE , Marcin Morawski 1EF , Emilia Kruk 1B , Łukasz Koperski 2BC , Krzysztof Zieniewicz 1EF , Marek Krawczyk 1AEF , Michał Grąt 1AEFDOI: 10.12659/AOT.941212
Ann Transplant 2023; 28:e941212
Figure 1 (A) Neuroendocrine liver metastases, hematoxylin and eosin staining, showing a well-differentiated tumor on the left side. (B) Neuroendocrine liver metastases, E-cadherin staining, showing loss of E-cadherin expression in tumor cells on the right side. Created using NDP.view2 (U12388-01), version 2.9.29, Hamamatsu Photonics.